The FDA's top drug regulator, Dr. George Tidmarsh, quit after federal officials began reviewing "serious concerns about his ...

D r. George Tidmarsh, the FDA drug regulator who was placed on leave and complained of a “toxic” work environment in an ...

(Reuters) -The director of the U.S. Food and Drug Administration's Center for Drug Evaluation and Research, George Tidmarsh, ...

The top drug regulator at the Food and Drug Administration (FDA) resigned Sunday, according to officials, after being accused ...

The Food and Drug Administration (FDA) just announced that over 580,000 bottles of blood pressure medications made by Teva ...

Parents and clinicians are urged to review usage of certain health products for young children after federal authorities ...

George Tidmarsh, the FDA's top drug regulator, has been placed on leave after being accused of abusing his regulatory ...

In a major setback, Uniqure said that the timing of when it can file its Huntington's treatment for FDA approval "is now ...

In any review of mifepristone, the FDA will now have to grapple with Judge Otake’s conclusion that the 2023 REMS decision for ...

The FDA released a new scientific analysis Friday, concluding that fluoride supplements have limited benefits for children’s ...

“The FDA is aware of reports of serious complications such as burns, scarring, fat loss, disfigurement, and nerve damage, ...